Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Sight Diagnostics

Sight Diagnostics

Sight is a blood diagnostic company based in Tel Aviv, Israel.

Sight’s analyzer machine, "OLO", performs a Complete Blood Count, a commonly ordered blood test. It can complete results in minutes. It’s compact: designed to be used in a mobile capacity.

Their analyzers create a digital version of blood, by capturing 1,000 highly detailed images of a finger prick sample, which is then interpreted by algorithms. Sight’s first product was focused on detecting Malaria, used in 24 countries, and has delivered almost 1 million tests to date.

History

Their OLO product came to fruition five years ago, with the introduction of Sight’s advanced algorithms to detect Malaria.

The solution enabled quick diagnoses using digital fluorescent microscopy and computer vision algorithms.

Timeline

August 2020
Sight Diagnostics raises a $71,000,000 series D round from Clal Biotechnology Industries, Go Capital, Koch Disruptive Technologies, Longliv Ventures, New Alliance Capital and OurCrowd.
2020
Sight Diagnostics was founded by Daniel Levner and Yossi Pollak.
February 2019
Sight Diagnostics raises a $27,800,000 series C round from Go Capital, Longliv Ventures, New Alliance Capital and OurCrowd.
December 23, 2018
Sight Diagnostics raises a $28,000,000 series B round.
September 2016
Sight Diagnostics raises a $16,000,000 series B round from GEOC, New Alliance Capital and OurCrowd.
November 2014
Sight Diagnostics raises a $6,000,000 series A round from Clal Biotechnology Industries, Emery Capital, Innovation Endeavors and OurCrowd.
August 2011
Sight Diagnostics raises a $3,000,000 seed round from Moshe Yanai and OurCrowd.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
June 23, 2021
WebWire
ZzappMalaria, the developer of a mobile-app and managerial dashboard that helps eliminate malaria, has won first place in the IBM Watson AI XPRIZE Competition as well as the People's Choice Award as the "Most Inspiring Team". As part of the award, the company will receive a $3 million prize to continue driving forward its mission of ridding the world of the deadly mosquito-borne disease. The IBM Watson AI for Good Competition was launched in 2016 to promote the use of AI to solve the...
May 25, 2021
WebWire
New York, NY -- May 25, 2021 -- Sight Diagnostics R, the company delivering lab-grade Complete Blood Count (CBC) results in minutes, announced today it has been named to the CNBC Disruptor 50, an annual list of forward-thinking and fast-growing private companies whose innovations are changing the world. This award comes in the same month that the company was recognized in the health category of Fast Company 2021 World Changing Ideas awards as well as in the 2021 Medical Design Ex...
April 22, 2021
WebWire
Tel Aviv, Israel (Apr 22, 2021) - Sight Diagnostics, the company delivering lab-grade Complete Blood Count (CBC) results in minutes, today announced a distribution partnership with Inter Medico to expand into Canada. Sight has received Health Canada approval to provide Sight OLOR analyzers to laboratories, ultimately enabling fast, accurate, 5-part differential blood testing across the country, especially in small rural and remote laboratories. The Canadian in-vitro diagnostics...
March 11, 2021
WebWire
OXFORD, United Kingdom (March 11, 2021) -- Sight Diagnostics ®, the company delivering lab-grade Full Blood Count (FBC) results in minutes, has deployed Sight OLO® at the John Radcliffe Hospital - part of the Oxford University Hospitals NHS Foundation Trust. The deployment allows rapid FBC testing, in minutes, for patients attending the emergency departments and is supporting validation of a rapid artificial-intelligence triage system for COVID-19. Sight OLO enables faster predictions...
February 16, 2021
WebWire
Tel Aviv, Israel (February 16, 2020) - ZzappMalaria, the developer of a mobile-app and online system that helps eliminate malaria, has been chosen as one of only three finalists from 10,000 interested teams in the IBM Watson XPRIZE "AI for Good'' challenge. ZzappMalaria has already received funding to continue its global fight against malaria, including a large-scale operation in Ghana and an ambitious plan to eliminate malaria from an island country, and will now compete for the $2.5M gr...
SHOW MORE

References

Golden logo
By using this site, you agree to our Terms & Conditions.